CIK 0001598646 · Non-accelerated filer<br>Smaller reporting company
Minerva Neurosciences, Inc.
Sign in to watch- Ticker
- NERV
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- MA
- Entity type
- operating
- EIN
- 260784194
- Phone
- 617-600-7373
- Business address
- 1500 DISTRICT AVENUE, BURLINGTON, MA, 01803
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2020-09-10 | VAN HEEK G JAN Director | Purchase | +7,000 | $2.97 | $21K | 20,333 |
| 2020-06-19 | Smith Devin Whittemore SVP and General Counsel | Grant or award · Employee Stock Option (right to buy) | +153,531 | 153,531 | ||
| 2020-06-19 | Saoud Jay SVP and Head of R&D | Grant or award · Employee Stock Option (right to buy) | +236,202 | 236,202 | ||
| 2020-06-19 | Russell Richard E. President | Grant or award · Employee Stock Option (right to buy) | +185,025 | 185,025 | ||
| 2020-06-19 | Reilly Joseph H. SVP & Chief Operating Officer | Grant or award · Employee Stock Option (right to buy) | +153,531 | 153,531 | ||
| 2020-06-19 | Race Geoff EVP, CFO & CBO | Grant or award · Employee Stock Option (right to buy) | +275,568 | 275,568 | ||
| 2020-06-19 | Luthringer Remy CEO | Grant or award · Employee Stock Option (right to buy) | +354,302 | 354,302 | ||
| 2020-06-19 | Davidson Michael Chief Medical Officer | Grant or award · Employee Stock Option (right to buy) | +137,784 | 137,784 | ||
| 2020-06-19 | Ahlholm Frederick W SVP, Chief Accounting Officer | Grant or award · Employee Stock Option (right to buy) | +137,784 | 137,784 | ||
| 2020-06-11 | VAN HEEK G JAN Director | Grant or award · Stock Option (right to buy) | +20,000 | 20,000 | ||
| 2020-06-11 | Laghrissi-Thode Fouzia Director | Grant or award · Stock Option (right to buy) | +20,000 | 20,000 | ||
| 2020-06-11 | Kupfer David Director | Grant or award · Stock Option (right to buy) | +20,000 | 20,000 | ||
| 2020-06-11 | HILLEMAN JERYL L Director | Grant or award · Stock Option (right to buy) | +20,000 | 20,000 | ||
| 2020-06-11 | HASLER HANS PETER Director | Grant or award · Stock Option (right to buy) | +20,000 | 20,000 | ||
| 2020-06-11 | DOYLE WILLIAM F Director | Grant or award · Stock Option (right to buy) | +40,000 | 40,000 | ||
| 2020-05-26 | Ahlholm Frederick W SVP, Chief Accounting Officer | Sale | −8,339 | $15.00 | $125K | 6,884 |
| 2019-12-31 | Smith Devin Whittemore SVP and General Counsel | Grant or award · Employee Stock Option (right to buy) | +41,469 | 41,469 | ||
| 2019-12-31 | Saoud Jay SVP and Head of R&D | Grant or award · Employee Stock Option (right to buy) | +63,798 | 63,798 | ||
| 2019-12-31 | Russell Richard E. President | Grant or award · Employee Stock Option (right to buy) | +49,975 | 49,975 | ||
| 2019-12-31 | Reilly Joseph H. SVP & Chief Operating Officer | Grant or award · Employee Stock Option (right to buy) | +41,469 | 41,469 |
Page 5 of 6 · 120 trades